Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3412-3421

Blackwell Publishing

Access to resources Recommend Favorite

A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer

By Wakelee Heather   Fisher George  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 241-242

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer

By Hoff Paulo   Saad Everardo   Pazdur Richard   Wolff Robert   Lassere Yvonne   Bogaard Karla   Abbruzzese James  

Investigational New Drugs, Vol. 22, Iss. 3, 2004-08 ,pp. : 307-313

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies

By Sayar H.   Shen Z.   Lee S.   Royce M.   Rabinowitz I.   Lee F.   Smith H.   Eberhardt S.   Maestas A.   Lu H.   Verschraegen C.  

Investigational New Drugs, Vol. 27, Iss. 2, 2009-04 ,pp. : 153-158

Springer Publishing Company

Access to resources Recommend Favorite

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: The reverse of the Will Rogers phenomenon?

By Fokas Emmanouil   Liersch Torsten   Fietkau Rainer   Hohenberger Werner   Hess Clemens   Becker Heinz   Sauer Rolf   Wittekind Christian   Rödel Claus  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1724-1727

Blackwell Publishing

Access to resources Recommend Favorite